Envista Holdings Corp (NVST)
19.76
+0.51
(+2.65%)
USD |
NYSE |
Sep 27, 16:00
19.77
+0.01
(+0.05%)
After-Hours: 20:00
Envista Holdings Research and Development Expense (TTM): 89.40M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 89.40M |
March 31, 2024 | 92.60M |
December 31, 2023 | 93.80M |
September 30, 2023 | 98.20M |
June 30, 2023 | 101.90M |
March 31, 2023 | 100.20M |
December 31, 2022 | 100.10M |
September 30, 2022 | 100.30M |
June 30, 2022 | 98.30M |
March 31, 2022 | 99.10M |
December 31, 2021 | 100.50M |
September 30, 2021 | 98.90M |
Date | Value |
---|---|
June 30, 2021 | 94.90M |
March 31, 2021 | 85.50M |
December 31, 2020 | 94.40M |
September 30, 2020 | 85.00M |
June 30, 2020 | 101.30M |
March 31, 2020 | 124.50M |
December 31, 2019 | 133.10M |
September 30, 2019 | 162.90M |
June 30, 2019 | 168.90M |
March 31, 2019 | 173.60M |
December 31, 2018 | 172.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
85.00M
Minimum
Sep 2020
162.90M
Maximum
Sep 2019
102.74M
Average
99.00M
Median
Research and Development Expense (TTM) Benchmarks
Align Technology Inc | 354.95M |
Dentsply Sirona Inc | 172.00M |
Biolase Inc | 5.368M |
Milestone Scientific Inc | 0.7566M |
Sonendo Inc | 9.32M |